LifeVantage Reports Financial Results for Q2 of 2026

Salt Lake City, Utah – LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, recently announced financial results for its second fiscal quarter ended December 31, 2025.

Second Quarter Fiscal 2026 Summary*:

• Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the first quarter.

• Revenue in the Americas decreased 32.6%, and revenue in Asia/Pacific & Europe decreased 2.1%.

• Net income per diluted share was $0.02, versus $0.19 per diluted share a year ago;

• Adjusted earnings per diluted share was $0.15, compared to $0.22 a year ago; and

• Adjusted EBITDA was $3.9 million compared to $6.5 million a year ago.

* All comparisons are on a year over year basis and compare the second quarter of fiscal 2026 to the second quarter of fiscal 2025, unless otherwise noted.

Steve Fife, President and CEO of LifeVantage said:

“The second quarter reflected challenging competitive dynamics in the weight loss market as we cycled the launch of our MindBody GLP-1 System™ in October 2024.

We acknowledge that our performance during the quarter did not meet your expectations or ours and we are redoubling our efforts to stabilize our GLP-1 business and make the other changes necessary to return to revenue growth.

While the growth trajectory of MindBody may have changed, we remain committed to this proven, scientifically validated natural weight loss solution.

We continue to be very well positioned across the broader health and wellness ecosystem and are particularly excited about the momentum we are seeing in LoveBiome^®, including several new products launching over the next couple quarters that will expand the portfolio into adjacent, high-growth categories.

This summer and beyond, LifeVantage also plans to expand into new international markets, another key element of our overall growth strategy. With a strong balance and proven track record of returning capital to shareholders, we remain steadfast in our commitment to driving long-term shareholder value.”

The company ended the period with cash and cash equivalents of $10.2 million, down from $20.2 million in the previous quarter, with no outstanding debt.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim^® family of products, TrueScience^® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84. Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System^®, as well as AXIO^® nootropic energy drink mixes, the full TrueScience^® line of skin and hair care products, and Petandim^®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.*